Bizzari Jean-Pierre insider trades
Bizzari Jean-Pierre has filed 11 Form 4s with the SEC that we hold, for ADC Therapeutics SA (ADCT) (Director), Aprea Therapeutics, Inc. (APRE) (Director) and Halozyme Therapeutics, INC. (HALO) (Director). Across all of them we count 0 purchases worth $0 and 2 sales worth $1.5M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 35,000 shares of Halozyme Therapeutics, INC. worth $1.4M, dated 2021-08-25. The first filing on our record is dated 2021-08-25 and the latest 2026-06-17.
ADC Therapeutics SA (ADCT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-06-17 | S, sale reported on Form 4 | 6,995 | $20.2K | 2024-06-18 |
Aprea Therapeutics, Inc. (APRE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Halozyme Therapeutics, INC. (HALO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-25 | S, sale reported on Form 4 | 35,000 | $1.4M | 2021-08-25 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1630914) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms